PAVmed
PAVmed is a commercial-stage medical technology company focused on improving patient care and saving lives through innovative products in the medical device, diagnostics, and digital health sectors.
PAVmed Company Overview
PAVmed is a commercial-stage, diversified medical technology company founded in 2014. The company's mission is to improve patient care and save lives. PAVmed operates primarily in the medical device, diagnostics, and digital health sectors. Its products focus on enabling preventative care, allowing physicians to monitor patients remotely, and helping healthcare systems operate more efficiently and cost-effectively. PAVmed employs a shared-services business model to achieve economies of scale and rapidly deploy resources across its operations.
PAVmed Founders
PAVmed was co-founded in 2014. The founders aimed to create a company focused on leveraging innovative medical technology to improve patient outcomes and streamline healthcare delivery. Under their leadership, PAVmed has developed a range of products and services designed to enhance patient care and support efficient medical practices.
PAVmed Products and Services
PAVmed offers a variety of medical technology products and services through its subsidiaries, Lucid Diagnostics and Veris Health. Lucid Diagnostics provides the first and only diagnostic test to detect esophageal precancer and cancer, including the EsoGuard® Esophageal DNA Test, which features over 90% sensitivity and specificity. They also developed EsoCheck® with Collect+Protect™ Technology, a non-endoscopic cell collection device. Veris Health specializes in personalized cancer care through remote patient monitoring, utilizing a digital health platform and connected health devices. These services aim to enhance preventative care, patient tracking, and efficient healthcare operations.
Lucid Diagnostics Initiatives
Lucid Diagnostics, a subsidiary of PAVmed, has launched significant initiatives in the field of esophageal cancer detection. It introduced the EsoGuard® Mobile Test Unit, the first mobile service for esophageal precancer detection. Additionally, Lucid Diagnostics held the inaugural #CheckYourFoodTube precancer testing event in collaboration with the San Antonio Fire Department. Lucid's diagnostic tools, such as the EsoGuard® Esophageal DNA Test and EsoCheck® with Collect+Protect™ Technology, are pivotal in identifying Barrett's esophagus and esophageal adenocarcinoma.
Veris Health and CancerX Partnership
Veris Health, a subsidiary of PAVmed, focuses on personalized cancer care by offering remote patient monitoring through a digital health platform and connected health devices. Veris Health is also a founding member of CancerX, a public-private partnership designed to foster innovation in cancer treatment. This collaboration underscores Veris Health's commitment to enhancing cancer care and leveraging technology to improve patient outcomes.